Neurocrine Biosciences, Inc. (NBIX) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $155.64 --0%
Revenue Growth %: +30.8%
Financial Fact:
General and administrative: 17.49M
Today's EPS Names:
CAN, UNFI, SUNB, More
Revenue Growth %: +30.8%
Financial Fact:
General and administrative: 17.49M
Today's EPS Names:
CAN, UNFI, SUNB, More
Join SI Premium – FREE
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) reported Q2 EPS of ($0.18), in-line with the analyst estimate of ($0.18).
For earnings history and earnings-related data on Neurocrine Biosciences, Inc. (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Morgan Stanley Downgrades Infineon Technologies (IFX:GY) (IFNNY) to Equalweight
- Prabhudas Lilladher Upgrades GE Vernova T&D India (GVTD:IN) to Buy (1)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
